BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37796644)

  • 1. Evolution of Response-Based Radiotherapy for Hepatocellular Cancer.
    Elaimy AL; Cao Y; Lawrence TS
    Cancer J; 2023 Sep-Oct 01; 29(5):266-271. PubMed ID: 37796644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
    Feng M; Suresh K; Schipper MJ; Bazzi L; Ben-Josef E; Matuszak MM; Parikh ND; Welling TH; Normolle D; Ten Haken RK; Lawrence TS
    JAMA Oncol; 2018 Jan; 4(1):40-47. PubMed ID: 28796864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.
    Jackson WC; Suresh K; Maurino C; Feng M; Cuneo KC; Ten Haken RK; Lawrence TS; Schipper MJ; Owen D
    Radiother Oncol; 2019 Dec; 141():101-107. PubMed ID: 31431377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
    Choi SH; Seong J
    Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis.
    Daniell KM; Banson KM; Diamond BH; Sioshansi S
    Curr Treat Options Oncol; 2022 Dec; 23(12):1761-1774. PubMed ID: 36333623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.
    Moon DH; Wang AZ; Tepper JE
    Radiother Oncol; 2018 Mar; 126(3):527-533. PubMed ID: 29366521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
    Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
    Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium.
    Shanker MD; Liu HY; Lee YY; Stuart KA; Powell EE; Wigg A; Pryor DI
    J Gastroenterol Hepatol; 2021 Apr; 36(4):873-884. PubMed ID: 32632941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
    Schaub SK; Hartvigson PE; Lock MI; Høyer M; Brunner TB; Cardenes HR; Dawson LA; Kim EY; Mayr NA; Lo SS; Apisarnthanarax S
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818790217. PubMed ID: 30068240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm).
    Sun J; Zhang T; Wang J; Li W; Zhang A; He W; Zhang D; Li D; Ding J; Duan X
    BMC Cancer; 2019 Aug; 19(1):846. PubMed ID: 31455251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
    Mitin T; Degnin C; Chen Y; Shirvani S; Gillespie E; Hoffe S; Latifi K; Nabavizadeh N; Dengina N; Chernich M; Usychkin S; Kharitonova E; Egorova Y; Pankratov A; Tsimafeyeu I; Thomas CR; Tjulandin S; Likhacheva A
    J Cancer Educ; 2020 Feb; 35(1):105-111. PubMed ID: 30467774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
    Chen YX; Zhuang Y; Yang P; Fan J; Zhou J; Hu Y; Zhu WC; Sun J; Zeng ZC
    Technol Cancer Res Treat; 2020; 19():1533033820937002. PubMed ID: 32613904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept.
    Price RG; Apisarnthanarax S; Schaub SK; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1349-1356. PubMed ID: 29932945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
    Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1953-1959. PubMed ID: 32052884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of stereotactic body radiation therapy for hepatocellular carcinoma.
    Sanuki N; Takeda A; Kunieda E
    World J Gastroenterol; 2014 Mar; 20(12):3100-11. PubMed ID: 24696597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.
    Toesca DAS; Osmundson EC; von Eyben R; Shaffer JL; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(3):173-182. PubMed ID: 28343896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
    De Bari B; Jumeau R; Deantonio L; Adib S; Godin S; Zeverino M; Moeckli R; Bourhis J; Prior JO; Ozsahin M
    Tumori; 2016 Oct; 102(5):e21-e24. PubMed ID: 27443895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
    Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma.
    Wu ZF; Zhang JY; Shen XY; Zhou LY; Gao YB; Hu Y; Zeng ZC
    Med Phys; 2016 Jul; 43(7):4349. PubMed ID: 27370150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.